Literature DB >> 18298470

British Society for Sexual Medicine guidelines on the management of erectile dysfunction.

Geoff Hackett1, Phil Kell, David Ralph, John Dean, David Price, Mark Speakman, Kevan Wylie.   

Abstract

INTRODUCTION: UK primary care physicians are required to follow authoritative endorsed guidelines as part of their terms of service. The major influence on the management of erectile dysfunction in primary and secondary care between 1999 and 2007 has been Department of Health "guidance on good practice," a non-evidence-based document, essentially defining patients who qualify for government-funded treatment. AIM: To provide clinically based guidelines relevant to UK primary and secondary healthcare professionals in their daily practice.
METHODS: A multidisciplinary panel of seven UK experts including two primary care physicians from the British Society for Sexual Medicine met for two full day meetings between September 2006 and April 2007, with each member allocated to disease areas related to their specialty. Feedback and approval of all sections between panel members was facilitated by the chairman. Source information was obtained from peer reviewed articles, meetings and presentations. Articles were chosen from electronically searching the Cochrane Library, Medline and Embase for randomized controlled clinical trials and graded according to level of evidence.
RESULTS: Patient-reported sexual activity, satisfaction with sexual activity (Male Sexual Health Questionnaire), and treatment expectations; urologists' subjective assessment of the importance given by their patients to ED; the timing they propose for starting ED treatment.
RESULTS: After the second full day meeting in January 2007, the final version was approved by panel members and made available for healthcare professions by download from http://www.bssm.org and from http://www.eguidelines.co.uk
CONCLUSIONS: A comprehensive evidence-based guideline has been developed that is highly relevant for primary and secondary care professionals enabling them to work within the unique requirements of the UK healthcare system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18298470     DOI: 10.1111/j.1743-6109.2008.00773.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  29 in total

1.  Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound.

Authors:  G Corona; E Mannucci; A D Fisher; F Lotti; E Bandini; L Vignozzi; G Balercia; F Paggi; L Petrone; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

Review 2.  Androgens are fundamental in the maintenance of male sexual health.

Authors:  Alvaro Morales
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

3.  Sildenafil citrate use in Addis Ababa: characteristics of users and pharmacists' dispensing practices.

Authors:  Dawit Teshome Gebregeorgise; Yajeb Melesse Belay; Sofia Kälvemark Sporrong
Journal:  Int J Clin Pharm       Date:  2017-11-14

Review 4.  Testosterone Replacement Therapy and Mortality in Older Men.

Authors:  G I Hackett
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

5.  Erectile dysfunction: a global review of intracavernosal injectables.

Authors:  Catriona Duncan; Ghadir J Omran; Jiasian Teh; Niall F Davis; Damien M Bolton; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2019-03-20       Impact factor: 4.226

6.  Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries.

Authors:  John P Mulhall; Tarek A Hassan; James Rienow
Journal:  Int J Clin Pract       Date:  2018-02-20       Impact factor: 2.503

7.  Erectile dysfunction: a window to the heart.

Authors:  Vitaliy Androshchuk; Neil Pugh; Andrew Wood; Nick Ossei-Gerning
Journal:  BMJ Case Rep       Date:  2015-04-28

8.  Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors.

Authors:  S Ji; Z Zang; H Ma; M Gu; Y Han; L Wang; S Jia; B Yang
Journal:  Int J Impot Res       Date:  2016-02-11       Impact factor: 2.896

9.  The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.

Authors:  Ajay Nehra; Graham Jackson; Martin Miner; Kevin L Billups; Arthur L Burnett; Jacques Buvat; Culley C Carson; Glenn R Cunningham; Peter Ganz; Irwin Goldstein; Andre T Guay; Geoff Hackett; Robert A Kloner; John Kostis; Piero Montorsi; Melinda Ramsey; Raymond Rosen; Richard Sadovsky; Allen D Seftel; Ridwan Shabsigh; Charalambos Vlachopoulos; Frederick C W Wu
Journal:  Mayo Clin Proc       Date:  2012-08       Impact factor: 7.616

Review 10.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.